Discover why software stocks thrive amid tariffs. Explore undervalued growth driven by AI and cloud spending with IGV ETF for ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...

We believe IGV-001 may offer meaningful clinical benefit for patients diagnosed with this deadly disease.” "Imvax concludes enrolment in Phase IIb glioblastoma treatment trial" was originally ...

As of 10:04:11 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

In May 2024, the company concluded participant enrolment for the Phase IIb trial of IGV-001 to treat ndGBM. "Imvax secures ...